Nuvelo Takes in $74.8M in Gross Proceeds from Common Stock Offering

Mar 09, 2004

NEW YORK, March 9 (GenomeWeb News) - Nuvelo has completed its common stock offering, resulting in approximately $74.8 million in gross proceeds, the company said yesterday.

Nuvelo sold 5.75 million shares in total, including 5 million shares from its public offering and 750,000 shares offered to underwriters as an option.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

Mysterious Third Group

An artificial intelligence-based analysis suggests a third group of ancient hominins likely interbred with human ancestors, according to Popular Mechanics.

This Week in Science

In Science this week: reduction in bee phylogenetic diversity, and more.

In the Past

The New York Times Magazine looks into paleogenomics and how it is revising what's know about human history, but also possibly ignoring lessons learned by archaeologists.

New Bases, New Drugs

The Economist reports on Synthorx's efforts to use expanded DNA bases they generated to develop a new cancer drug.

Main menu